Department Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, China.
Institute of Digestive Diseases, The Chinese University of Hong Kong, Shatin, China.
Gut. 2020 Feb;69(2):304-310. doi: 10.1136/gutjnl-2018-318117. Epub 2019 Apr 26.
The risk associated with a family history of non-advanced adenoma (non-AA) is unknown. We determined the prevalence of colorectal neoplasms in subjects who have a first-degree relative (FDR) with non-AA compared with subjects who do not have an FDR with adenomas.
In a blinded, cross-sectional study, consecutive subjects with newly diagnosed non-AA were identified from our colonoscopy database. 414 FDRs of subjects with non-AA (known as exposed FDRs; mean age 55.0±8.1 years) and 414 age and sex-matched FDRs of subjects with normal findings from colonoscopy (known as unexposed FDRs; mean age 55.2±7.8 years) underwent a colonoscopy from November 2015 to June 2018. One FDR per family was recruited. FDRs with a family history of colorectal cancer were excluded. The primary outcome was prevalence of advanced adenoma (AA). Secondary outcomes included prevalence of all adenomas and cancer.
The prevalence of AA was 3.9% in exposed FDRs and 2.4% in unexposed FDRs (matched OR (mOR)=1.67; 95% CI 0.72 to 3.91; p=0.238 adjusted for proband sex and proband age). Exposed FDRs had a higher prevalence of any adenomas (29.2% vs 18.6%; mOR=1.87; 95% CI 1.32 to 2.66; p<0.001) and non-AA (25.4% vs 16.2%; mOR=1.91; 95% CI 1.32 to 2.76; p=0.001). A higher proportion of exposed FDRs than unexposed FDRs (4.3% vs 2.2%; adjusted mOR=2.44; 95% CI 1.01 to 5.86; p=0.047) had multiple adenomas. No cancer was detected in both groups.
A positive family history of non-AA does not significantly increase the risk of clinically important colorectal neoplasia. The data support current guidelines which do not advocate earlier screening in individuals with a family history of non-AA.
NCT0252172.
有非高级别腺瘤(non-AA)家族史的风险尚不清楚。我们确定了与无腺瘤一级亲属(FDR)的受试者相比,有 FDR 有非 AA 病史的受试者中结直肠肿瘤的患病率。
在一项盲法、横断面研究中,我们从结肠镜数据库中确定了新诊断为非 AA 的连续受试者。414 名有非 AA 病史受试者的 FDR(称为暴露 FDR;平均年龄 55.0±8.1 岁)和 414 名结肠镜检查结果正常受试者的 FDR(称为未暴露 FDR;平均年龄 55.2±7.8 岁)在 2015 年 11 月至 2018 年 6 月期间接受了结肠镜检查。每个家庭招募一个 FDR。排除有结直肠癌家族史的 FDR。主要结局是高级别腺瘤(AA)的患病率。次要结局包括所有腺瘤和癌症的患病率。
暴露 FDR 中 AA 的患病率为 3.9%,未暴露 FDR 中为 2.4%(匹配 OR(mOR)=1.67;95%CI 0.72 至 3.91;p=0.238,校正了先证者性别和先证者年龄)。暴露 FDR 的任何腺瘤(29.2%比 18.6%;mOR=1.87;95%CI 1.32 至 2.66;p<0.001)和非 AA(25.4%比 16.2%;mOR=1.91;95%CI 1.32 至 2.76;p=0.001)的患病率更高。与未暴露 FDR 相比,暴露 FDR 中(4.3%比 2.2%;调整 mOR=2.44;95%CI 1.01 至 5.86;p=0.047)有更多的多发性腺瘤。两组均未发现癌症。
非 AA 家族史阳性并不显著增加结直肠重要肿瘤的风险。数据支持目前的指南,即不主张对有非 AA 家族史的个体进行早期筛查。
NCT0252172。